This year has been full of positive catalysts for RGNX. As RGNX continues to build out their clinical pipeline, data catalyst from upcoming phase 2a report on their Wet-AMD gene therapy product could send the stock roaring higher. RGNX is set to report data Oct. 13, 2019 and the companies technical setup is quite nice. The Wet-AMD market is a lucrative opportunity and proving the previous offering was worth the time and R&D to investors with good data will re-ignite excitement and investment. Although market conditions have been terrible lately, RGNX has held up great (I interpret this as positive sentiment going into data).
I have outlined and noted bullish patterns I will be watching.
One-Year-high: $85.10, July 09, 2018
Cup and Handle formation starting date of IPO (Stock has retraced to bullish .707 harmonic retracement level from the July 2018 high).
Recent low of $30 has significant price structure to hold current support.
$30 also marked "oversold" territory and double bottom on the one-year chart.
Symmetrical patterns portray controlled accumulation/ distribution in downtrend.
Recent price spikes indicate Bulls buying back in for potential run-up on good data.
RSI and CCI moving toward positive slopes.
Fibonnacci support levels converge with July 09, 2018 high.
Levels to Watch -- Levels I will be watching to add range from current price ($35) down to $30.40 -- Structural levels (highlighted in horizontal rectangular box) -- Support levels (horizontal lines on chart) price needs to hold range from $30 -> $26
Please like and follow us here so I can continue finding awesome charts and money moves. Thanks in advance!
Disclosure: I am long RGNX. I may buy or sell within the next 72 hours. This is not a recommendation to buy or sale, please do your homework before investing.
Check my recent move with Conformis Inc. (Nasdaq: CFMS), gaining over 30% move today
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.